Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Usana Health Sciences (USNA) Current Leases (2019)

Usana Health Sciences (USNA) has disclosed Current Leases for 1 consecutive years, with $8.3 million as the latest value for Q4 2019.

Quarterly Current Leases changed N/A to $8.3 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $8.3 million through Dec 2019, changed N/A year-over-year, with the annual reading at $8.3 million for FY2019, N/A changed from the prior year.
Current Leases for Q4 2019 was $8.3 million at Usana Health Sciences.
The five-year high for Current Leases was $8.3 million in Q4 2019, with the low at $8.3 million in Q4 2019.